Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

On July 8, 2025, the world watched as King Charles III welcomed French President Emmanuel Macron and his wife, Brigitte, to ...

King Charles was pictured with a burst blood vessel in his right eye during a state visit from French President Emmanuel ...

Objective Owing to the paucity of data, this study aimed to investigate sex differences in clinical features and prognosis of patients with cardiac sarcoidosis (CS). Methods This study was a secondary ...

In other instances, the condition can impact quality of life. But in extreme cases, sarcoidosis can be life-threatening. So, ...